Yiling Pharmaceutical: The first three quarters of revenue and net profit attributable to the parent company exceed the full year of 2019. Innovation drives sustainable development

Caishen.Co delivers Primary Data for China`s Secondary Investment and Stock Markets. Full details at Caishen.Co.

Comments are closed.